{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:39:19Z","timestamp":1794109159459,"version":"4.8.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Mater."],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41563-024-02116-3","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T05:13:36Z","timestamp":1740719616000},"page":"1840-1851","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["High-density brush-shaped polymer lipids reduce anti-PEG antibody binding for repeated administration of mRNA therapeutics"],"prefix":"10.1038","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5604-7479","authenticated-orcid":false,"given":"Yufen","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xizhen","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0215-6095","authenticated-orcid":false,"given":"Yehui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Chieh","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0712-659X","authenticated-orcid":false,"given":"Amogh","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1584-2417","authenticated-orcid":false,"given":"Zexiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5295-180X","authenticated-orcid":false,"given":"Ankit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumanta","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7607-1225","authenticated-orcid":false,"given":"Lining","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2076-3537","authenticated-orcid":false,"given":"Erick","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8925-5645","authenticated-orcid":false,"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4107-1676","authenticated-orcid":false,"given":"Lukas","family":"Farbiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8085-7770","authenticated-orcid":false,"given":"Marc I.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5972-508X","authenticated-orcid":false,"given":"Cecilia","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey G.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3823-1931","authenticated-orcid":false,"given":"Daniel J.","family":"Siegwart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"2116_CR1","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/s41587-022-01491-z","volume":"40","author":"E Rohner","year":"2022","unstructured":"Rohner, E., Yang, R., Foo, K. S., Goedel, A. & Chien, K. R. Unlocking the promise of mRNA therapeutics. Nat. Biotechnol. 40, 1586\u20131600 (2022).","journal-title":"Nat. Biotechnol."},{"key":"2116_CR2","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/hep.32441","volume":"76","author":"N Zabaleta","year":"2022","unstructured":"Zabaleta, N., Torella, L., Weber, N. D. & Gonzalez-Aseguinolaza, G. mRNA and gene editing: late breaking therapies in liver diseases. Hepatology 76, 869\u2013887 (2022).","journal-title":"Hepatology"},{"key":"2116_CR3","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/cells11203328","volume":"11","author":"ML Cacicedo","year":"2022","unstructured":"Cacicedo, M. L., Limeres, M. J. & Gehring, S. mRNA-based approaches to treating liver diseases. Cells 11, 3328 (2022).","journal-title":"Cells"},{"key":"2116_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin, S. et al. mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduct. Target. Ther. 7, 166 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2116_CR5","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1039\/D1CS00617G","volume":"51","author":"Y Xiao","year":"2022","unstructured":"Xiao, Y. et al. Emerging mRNA technologies: delivery strategies and biomedical applications. Chem. Soc. Rev. 51, 3828\u20133845 (2022).","journal-title":"Chem. Soc. Rev."},{"key":"2116_CR6","doi-asserted-by":"publisher","first-page":"17056","DOI":"10.1038\/natrevmats.2017.56","volume":"2","author":"KA Hajj","year":"2017","unstructured":"Hajj, K. A. & Whitehead, K. A. Tools for translation: non-viral materials for therapeutic mRNA delivery. Nat. Rev. Mater. 2, 17056 (2017).","journal-title":"Nat. Rev. Mater."},{"key":"2116_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","volume":"29","author":"JR Mendell","year":"2021","unstructured":"Mendell, J. R. et al. Current clinical applications of in vivo gene therapy with AAVs. Mol. Ther. 29, 464\u2013488 (2021).","journal-title":"Mol. Ther."},{"key":"2116_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30102-3","volume":"13","author":"M Milani","year":"2022","unstructured":"Milani, M. et al. Liver-directed lentiviral gene therapy corrects hemophilia A mice and achieves normal-range factor VIII activity in non-human primates. Nat. Commun. 13, 2454 (2022).","journal-title":"Nat. Commun."},{"key":"2116_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41587-020-0741-7","volume":"39","author":"GN Nguyen","year":"2021","unstructured":"Nguyen, G. N. et al. A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells. Nat. Biotechnol. 39, 47\u201355 (2021).","journal-title":"Nat. Biotechnol."},{"key":"2116_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26830-7","volume":"12","author":"CH Hakim","year":"2021","unstructured":"Hakim, C. H. et al. Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models. Nat. Commun. 12, 6769 (2021).","journal-title":"Nat. Commun."},{"key":"2116_CR11","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nbt.3469","volume":"34","author":"Y Yang","year":"2016","unstructured":"Yang, Y. et al. A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice. Nat. Biotechnol. 34, 334\u2013338 (2016).","journal-title":"Nat. Biotechnol."},{"key":"2116_CR12","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41591-018-0209-1","volume":"24","author":"L Villiger","year":"2018","unstructured":"Villiger, L. et al. Treatment of a metabolic liver disease by in vivo genome base editing in adult mice. Nat. Med. 24, 1519\u20131525 (2018).","journal-title":"Nat. Med."},{"key":"2116_CR13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ymthe.2023.01.010","volume":"31","author":"M Schulz","year":"2023","unstructured":"Schulz, M. et al. Binding and neutralizing anti-AAV antibodies: detection and implications for rAAV-mediated gene therapy. Mol. Ther. 31, 616\u2013630 (2023).","journal-title":"Mol. Ther."},{"key":"2116_CR14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/gt.2011.90","volume":"19","author":"C Li","year":"2012","unstructured":"Li, C. et al. Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia. Gene Ther. 19, 288\u2013294 (2012).","journal-title":"Gene Ther."},{"key":"2116_CR15","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1089\/hum.2009.182","volume":"21","author":"S Boutin","year":"2010","unstructured":"Boutin, S. et al. Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors. Hum. Gene Ther. 21, 704\u2013712 (2010).","journal-title":"Hum. Gene Ther."},{"key":"2116_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","volume":"8","author":"P Colella","year":"2018","unstructured":"Colella, P., Ronzitti, G. & Mingozzi, F. Emerging issues in AAV-mediated in vivo gene therapy. Mol. Ther. Methods Clin. Dev. 8, 87\u2013104 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2116_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","volume":"8","author":"SA Dilliard","year":"2023","unstructured":"Dilliard, S. A. & Siegwart, D. J. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat. Rev. Mater. 8, 282\u2013300 (2023).","journal-title":"Nat. Rev. Mater."},{"key":"2116_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41563-020-00886-0","volume":"20","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Mater. 20, 701\u2013710 (2021).","journal-title":"Nat. Mater."},{"key":"2116_CR19","doi-asserted-by":"publisher","first-page":"9243","DOI":"10.1021\/acsnano.0c04707","volume":"14","author":"T Wei","year":"2020","unstructured":"Wei, T. et al. Delivery of tissue-targeted scalpels: opportunities and challenges for in vivo CRISPR\/Cas-based genome editing. ACS Nano 14, 9243\u20139262 (2020).","journal-title":"ACS Nano"},{"key":"2116_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Nanotechnol. 15, 313\u2013320 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"2116_CR21","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"2116_CR22","doi-asserted-by":"publisher","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","volume":"16","author":"Y Ju","year":"2022","unstructured":"Ju, Y. et al. Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine. ACS Nano 16, 11769\u201311780 (2022).","journal-title":"ACS Nano"},{"key":"2116_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1021\/bm401812r","volume":"15","author":"C Garofalo","year":"2014","unstructured":"Garofalo, C. et al. Different insight into amphiphilic PEG-PLA copolymers: influence of macromolecular architecture on the micelle formation and cellular uptake. Biomacromolecules 15, 403\u2013415 (2014).","journal-title":"Biomacromolecules"},{"key":"2116_CR24","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1021\/acs.molpharmaceut.9b01288","volume":"17","author":"K Zhou","year":"2020","unstructured":"Zhou, K. et al. Hydrophobic domain structure of linear-dendritic poly(ethylene glycol) lipids affects RNA delivery of lipid nanoparticles. Mol. Pharm. 17, 1575\u20131585 (2020).","journal-title":"Mol. Pharm."},{"key":"2116_CR25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109256118","volume":"118","author":"SA Dilliard","year":"2021","unstructured":"Dilliard, S. A., Cheng, Q. & Siegwart, D. J. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc. Natl Acad. Sci. USA 118, e2109256118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2116_CR26","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0006-3495(95)80369-3","volume":"68","author":"AK Kenworthy","year":"1995","unstructured":"Kenworthy, A. K., Hristova, K., Needham, D. & McIntosh, T. J. Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol). Biophys. J. 68, 1921\u20131936 (1995).","journal-title":"Biophys. J."},{"key":"2116_CR27","doi-asserted-by":"publisher","first-page":"7785","DOI":"10.1039\/C4TB01383B","volume":"2","author":"L Bai","year":"2014","unstructured":"Bai, L., Tan, L., Chen, L., Liu, S. & Wang, Y. Preparation and characterizations of poly(2-methyl-2-oxazoline) based antifouling coating by thermally induced immobilization. J. Mater. Chem. B 2, 7785\u20137794 (2014).","journal-title":"J. Mater. Chem. B"},{"key":"2116_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0169-409X(95)00029-7","volume":"16","author":"TM Allen","year":"1995","unstructured":"Allen, T. M., Hansen, C. B. & de Menezes, D. E. L. Pharmacokinetics of long-circulating liposomes. Adv. Drug Deliv. Rev. 16, 267\u2013284 (1995).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2116_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jconrel.2016.05.059","volume":"235","author":"S Chen","year":"2016","unstructured":"Chen, S. et al. Influence of particle size on the in vivo potency of lipid nanoparticle formulations of sirna. J. Control. Release 235, 236\u2013244 (2016).","journal-title":"J. Control. Release"},{"key":"2116_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0168-3659(01)00331-5","volume":"74","author":"RB Greenwald","year":"2001","unstructured":"Greenwald, R. B. PEG drugs: An overview. J. Control. Release 74, 159\u2013171 (2001).","journal-title":"J. Control. Release"},{"key":"2116_CR31","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1126\/science.8128245","volume":"263","author":"R Gref","year":"1994","unstructured":"Gref, R. et al. Biodegradable long-circulating polymeric nanospheres. Science 263, 1600\u20131603 (1994).","journal-title":"Science"},{"key":"2116_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrd1033","volume":"2","author":"JM Harris","year":"2003","unstructured":"Harris, J. M. & Chess, R. B. Effect of PEGylation on pharmaceuticals. Nat. Rev. Drug Discov. 2, 214\u2013221 (2003).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2116_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2021.12.033","volume":"342","author":"C Stavnsbjerg","year":"2022","unstructured":"Stavnsbjerg, C. et al. Accelerated blood clearance and hypersensitivity by PEGylated liposomes containing TLR agonists. J. Control. Release 342, 337\u2013344 (2022).","journal-title":"J. Control. Release"},{"key":"2116_CR34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jconrel.2021.05.001","volume":"334","author":"SE Emam","year":"2021","unstructured":"Emam, S. E. et al. Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice. J. Control. Release 334, 327\u2013334 (2021).","journal-title":"J. Control. Release"},{"key":"2116_CR35","first-page":"86","volume":"37","author":"DD Kang","year":"2024","unstructured":"Kang, D. D. et al. Engineering LNPs with polysarcosine lipids for mRNA delivery. Bioact. Mater. 37, 86\u201393 (2024).","journal-title":"Bioact. Mater."},{"key":"2116_CR36","doi-asserted-by":"crossref","unstructured":"Da Silva Sanchez, A. J. et al. Substituting poly(ethylene glycol) lipids with poly(2-ethyl-2-oxazoline) lipids improves lipid nanoparticle repeat dosing. Adv. Healthc. Mater. 13, 2304033 (2024).","DOI":"10.1002\/adhm.202304033"},{"key":"2116_CR37","doi-asserted-by":"publisher","first-page":"19466","DOI":"10.1021\/jacs.2c07859","volume":"144","author":"J Chen","year":"2022","unstructured":"Chen, J., Rizvi, A., Patterson, J. P. & Hawker, C. J. Discrete libraries of amphiphilic poly(ethylene glycol) graft copolymers: synthesis, assembly, and bioactivity. J. Am. Chem. Soc. 144, 19466\u201319474 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"2116_CR38","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1126\/science.adk9428","volume":"384","author":"Y Sun","year":"2024","unstructured":"Sun, Y. et al. In vivo editing of lung stem cells for durable gene correction in mice. Science 384, 1196\u20131202 (2024).","journal-title":"Science"},{"key":"2116_CR39","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/s41565-024-01680-8","volume":"19","author":"X Lian","year":"2024","unstructured":"Lian, X. et al. Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells. Nat. Nanotechnol. 19, 1409\u20131417 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"2116_CR40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","volume":"18","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery. Nat. Protoc. 18, 265\u2013291 (2023).","journal-title":"Nat. Protoc."}],"updated-by":[{"DOI":"10.1038\/s41563-025-02270-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000}}],"container-title":["Nature Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41563-024-02116-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41563-024-02116-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41563-024-02116-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:09:12Z","timestamp":1761847752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41563-024-02116-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2116"],"URL":"https:\/\/doi.org\/10.1038\/s41563-024-02116-3","relation":{},"ISSN":["1476-1122","1476-4660"],"issn-type":[{"value":"1476-1122","type":"print"},{"value":"1476-4660","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"5 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41563-025-02270-2","URL":"https:\/\/doi.org\/10.1038\/s41563-025-02270-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of Texas Southwestern has filed patent applications on the technologies described in this manuscript with some co-authors listed as inventors. D.J.S. discloses financial interests in ReCode Therapeutics, Signify Bio, Jumble Therapeutics and Tome Biosciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}